SCHEMBL7349901

SCHEMBL7349901

COc1cc(O)c(F)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 3/20 0.51
LCK P06239 1/20 0.50
FYN P06241 1/20 0.50
PTGS2 P35354 1/20 0.50
HTT P42858 4/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
PYGL P06737 1/20 0.47
HSD17B10 Q99714 3/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA3 P07451 1/20 0.44
PKM P14618 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931203 0.86 ALDH1A1 (0.56) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL3423769 0.85 ALDH1A1 (0.55) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL15524015 0.84 KDM4E (0.58) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL7347988 0.84 GAA (0.50) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL23905419 0.84 HTT (0.46) KDM4EALDH1A1HPGDPTGS2HTT
SCHEMBL20724883 0.82 HTT (0.57) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL19667102 0.81 LCK (0.65) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL18713914 0.81 ALDH1A1 (0.51) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL2596409 0.80 ALDH1A1 (0.54) KDM4EALDH1A1HPGDLCKFYN
SCHEMBL2664109 0.80 CTSD (0.50) KDM4EALDH1A1HTTLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5726172-A BENZOXAZINONE DERIVATIVES; TREATMENT OF PRETERM LABOR, DYSMENORRHEA MERCK & CO., INC. (US) 1998-03-10 US disclosed
WO-1997025992-A1 TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-07-24 WO disclosed